Doç. Dr. LEYLA BAHAR
- Yöksis ID 105192
- Researcher ID Y-3908-2019
- ORCID ID 0000-0002-6910-6167
- Scopus ID 55682450000
- Scholar ID P-3890-2015
- E-posta leylabahar@mersin.edu.tr
- Dahili Telefon 21793
Birim
SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU
TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ
İLK VE ACİL YARDIM PR.
TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ
İLK VE ACİL YARDIM PR.
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Histoloji ve Embriyoloji
Histoloji ve Embriyoloji
Son 5 Makale
The Effect of Amygdalin Pretreatment on Ovarian Follicles in RatsExposed to CCL4
MITTEILUNGEN KLOSTERNEUBURG, vol. , no. , pp. –
Therapeutic and prophylactic roles of oleuropein in experimental acute lung injury: Modulation of tumor necrosis factor-α and nuclear factor erythroid 2-related factor 2 pathways
EXPERIMENTAL AND THERAPEUTIC MEDICINE, vol. 32, no. 2, pp. 1–9 Link 2026
Next-generation heparin antidotes: "Exosomes as a biocompatible alternative to protamine sulfate"
MOLECULAR BIOLOGY REPORTS, vol. 53, no. 1, pp. – Link 2026
Next-generation heparin antidotes: “Exosomes as a biocompatible alternative to protamine sulfate”
Molecular Biology Reports, vol. 53, no. , pp. – Link 2026
Evaluation of miRNA-133a-3p and miRNA-124-3p expression in atherosclerosis using real-time PCR and immunohistochemical methods
The Indian Journal of Medical Research, vol. 163, no. , pp. 24–30 Link 2026
MITTEILUNGEN KLOSTERNEUBURG, vol. , no. , pp. –
Therapeutic and prophylactic roles of oleuropein in experimental acute lung injury: Modulation of tumor necrosis factor-α and nuclear factor erythroid 2-related factor 2 pathways
EXPERIMENTAL AND THERAPEUTIC MEDICINE, vol. 32, no. 2, pp. 1–9 Link 2026
Next-generation heparin antidotes: "Exosomes as a biocompatible alternative to protamine sulfate"
MOLECULAR BIOLOGY REPORTS, vol. 53, no. 1, pp. – Link 2026
Next-generation heparin antidotes: “Exosomes as a biocompatible alternative to protamine sulfate”
Molecular Biology Reports, vol. 53, no. , pp. – Link 2026
Evaluation of miRNA-133a-3p and miRNA-124-3p expression in atherosclerosis using real-time PCR and immunohistochemical methods
The Indian Journal of Medical Research, vol. 163, no. , pp. 24–30 Link 2026
Son 5 Bildiri
SENOLYTIC (“ZOMBIE CELL”) THERAPIES FOR EYE DISEASES
5. INTERNATIONAL PARIS SCIENTIFIC RESEARCH AND INNOVATION CONGRESS BOOK 23-24 MAY 2026, FRANCE (23.05.2026 - 24.05.2026) Link 2026
A PARADIGM SHIFT IN GLAUCOMA TREATMENT: MIGS, DIGITAL MONITORING AND THE INTEGRATION OF ARTIFICIAL INTELLIGENCE
5.. INTERNATIONAL PARIS SCIENTIFIC RESEARCH AND INNOVATION CONGRESS May 23-24, 2026 FRANCE (23.05.2026 - 24.05.2026) Link 2026
Oleuropein’in oleik asit kaynaklı akut akciğer hasarı üzerine etkisi
13. Ulusal Göğüs Cerrahisi Kongresi (16.10.2025 - ) Link 2025
ONE OF THE DYNAMICS OF THE HEALTH SECTOR IN OUR CENTURY: THE PLACE OF EXOSOMES IN DIAGNOSIS AND TREATMENT
X. ASC 2025-YAPAY ZEKA ÇAĞINDA GEZEGEN, İNSANLAR VE BARIŞ (16.10.2025 - 18.10.2025) Link 2025
HİSTOPATOLOJİK TANIDA YAPAY ZEKA: 21. YÜZYILIN YENİ ASİSTANI
X. ASC 2025-YAPAY ZEKA ÇAĞINDA GEZEGEN, İNSANLAR VE BARIŞ (18.10.2025 - 18.10.2025) Link 2025
5. INTERNATIONAL PARIS SCIENTIFIC RESEARCH AND INNOVATION CONGRESS BOOK 23-24 MAY 2026, FRANCE (23.05.2026 - 24.05.2026) Link 2026
A PARADIGM SHIFT IN GLAUCOMA TREATMENT: MIGS, DIGITAL MONITORING AND THE INTEGRATION OF ARTIFICIAL INTELLIGENCE
5.. INTERNATIONAL PARIS SCIENTIFIC RESEARCH AND INNOVATION CONGRESS May 23-24, 2026 FRANCE (23.05.2026 - 24.05.2026) Link 2026
Oleuropein’in oleik asit kaynaklı akut akciğer hasarı üzerine etkisi
13. Ulusal Göğüs Cerrahisi Kongresi (16.10.2025 - ) Link 2025
ONE OF THE DYNAMICS OF THE HEALTH SECTOR IN OUR CENTURY: THE PLACE OF EXOSOMES IN DIAGNOSIS AND TREATMENT
X. ASC 2025-YAPAY ZEKA ÇAĞINDA GEZEGEN, İNSANLAR VE BARIŞ (16.10.2025 - 18.10.2025) Link 2025
HİSTOPATOLOJİK TANIDA YAPAY ZEKA: 21. YÜZYILIN YENİ ASİSTANI
X. ASC 2025-YAPAY ZEKA ÇAĞINDA GEZEGEN, İNSANLAR VE BARIŞ (18.10.2025 - 18.10.2025) Link 2025